MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Bradykinesia"

  • MDS Virtual Congress 2021

    Prasinezumab reduced progression of Parkinson’s disease motor features measured by Roche PD Mobile Application v2 sensor features: PASADENA Phase II Part 1

    K. Taylor, F. Lipsmeier, E. Volkova-Volkmar, D. Rukina, J. Anzures Cabrera, L. Essioux, M. Abt, B. van Lier, A. Thomann, H. Svoboda, W. Zago, R. Postuma, G. Pagano, M. Lindemann (Basel, Switzerland)

    Objective: To determine whether digital biomarker sensor data detect slowing in progression of core motor features of Parkinson’s disease (PD) in individuals with early PD…
  • MDS Virtual Congress 2021

    Early-onset vs. Late-onset Parkinson’s disease

    H. Slimène, N. Farhat, S. Sakka, O. Hdiji, M. Dammak, C. Mhiri (Sousse, Tunisia)

    Objective: To determine the clinical and therapeutic peculiarities that distinguish Early onset Parkinson’s disease (EOPD) from late onset Parkinson’s disease (LOPD). Background: Age is the…
  • MDS Virtual Congress 2021

    “Striatal Hand Signs” and early diagnosis of Parkinson’s Disease: The “Monkey-Wrench Sign”.

    I. Teixeira, V. Souza, C. Zorzenon, B. Veiga, V. Borges, H. Ferraz (São Paulo, Brazil)

    Objective: To identify signs of hand deformations in PD patients with earlier diseases, and compare with intermediate and late phases patients. Background: “Striatal hand signs”,…
  • MDS Virtual Congress 2021

    Parkinson’s-disease risk variants are differentially associated with discrete phenotypic characteristics of Parkinson’s-disease at baseline.

    B. Chase, A. Premkumar, B. Schoneburg, N. Kartha, J. Wei, H. Yu, A. Epshteyn, L. Garduno, A. Pham, R. Vazquez, R. Frigerio, D. Maraganore, K. Markopoulou (Skokie, USA)

    Objective: Evaluate whether genetic risk variants for Parkinson’s disease discovered in case-control GWAS uniformly or differentially contribute to the clinical phenotype of PD. Background: Genetic…
  • MDS Virtual Congress 2021

    Motor Function Test Protocol for Parkinsonian Triad in Rodent Model of Parkinson’s Disease

    M. Sirajo, K. Murtala, J. Oyem, O. Ishola, O. Lukman (Kano, Nigeria)

    Objective: To review motor deficits protocols and create a set of behavioural protocols that critically address the parkinsonian triad's quantification in Parkinson's disease models. Background:…
  • MDS Virtual Congress 2021

    Longitudinal Speech Changes In PD and the Relationship to Limb Bradykinesia and Rigidity

    R. Richter, S. Gutierrez, R. Bennett, C. Deckelman, F. Docters, A. Lang, D. Breen, C. Marras, M. Masellis, D. Grimes, M. Jog, B. Tan, K. Sunderland, JB. Orange, P. Mclaughlin, A. Troyer, B. Levine, D. Beaton, M. Binns, D. Munoz, R. Swartz, A. Roberts (Evanston, USA)

    Objective: We tested the assumption that speech diadochokinesis (DDK) in Parkinson’s disease (PD) parallels motor system performances by evaluating DDK changes over 12-months and testing if DDK performance predicts limb bradykinesia and rigidity UPDRS scores. Background: Studies showing that speech DDK correlates with…
  • MDS Virtual Congress 2021

    ‘Asymmetric thumb-index angle’ in PD: A new observation in an old disease

    J. Siddiqui (Columbia, USA)

    Objective: To report a novel sign on inspection in PD that is present throughout different dopaminergic states Background: Inspection is arguably one of the most…
  • MDS Virtual Congress 2021

    Wearable Devices in Movement Disorder Trials to Provide Objective Measures

    C. Martino, A. Lledó, J. Hamlet, S. Mendick (Wilmington, USA)

    Objective: To understand the validity of wearable devices in capturing objective motor and nonmotor symptoms of Parkinson’s Disease (PD) in addition to what has been…
  • MDS Virtual Congress 2020

    Compartment-specific blockade of dopamine uptake in nigrostriatal pathway reveals role for nigral dopamine function in movement frequency in open-field

    M. Salvatore, E. Kasanga, K. Lanza, S. Meadows, A. Centner, C. Bishop (Fort Worth, TX, USA)

    Objective: Inhibition of tyrosine hydroxylase activity in the substantia nigra (SN) produces a significant reduction in locomotor motor activity commensurate with decreased dopamine (DA) content…
  • MDS Virtual Congress 2020

    Smartphone-based context awareness to improve ambulatory Parkinson’s monitoring

    A. Hadley, B. Walter, A. Espay, D. Heldman (Cleveland, OH, USA)

    Objective: To determine the utility of context-awareness algorithms based on sensors in smartphones to improve ambulatory Parkinson’s disease (PD) monitoring. Background: Previous research shows that optimal motion sensor-based ambulatory PD monitoring requires multiple sensors to…
  • « Previous Page
  • 1
  • …
  • 7
  • 8
  • 9
  • 10
  • 11
  • …
  • 24
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley